Propylthiouracil-induced hypothyroid hyperlipidemic chick: a model for clofibrate-induced toxicity.
An animal model for clinically observed clofibrate (p-chlorophenoxy isobutyrate, CPIB)-induced toxicity has been tested. It is demonstrated that propylthiouracil-induced hypothyroid-hyperlipidemic chick develops severe toxic manifestations following clofibrate administration. Toxic symptoms are characterized by listlessness, drowziness, and extreme muscular weakness. This is associated with elevation of blood urea nitrogen, creatine phosphokinase, uric acid and glutamic oxaloacetic transaminase. Histological examination of muscle specimen from chicks exhibiting toxic syndrome showed degeneration and vacuolization of muscle fibers. The biochemical and histological changes observed are quite similar to those reported in clinical practice in some patients given clofibrate. It is suggested that this chick model could be used to investigate the biochemical basis of clofibrate toxicity.
D000818:Animals; D002645:Chickens; D002994:Clofibrate / Q000633:toxicity*; D006949:Hyperlipidemias / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D007037:Hypothyroidism / Q000139:chemically induced / Q000150:complications* / Q000473:pathology; D008297:Male; D009132:Muscles / Q000473:pathology*; D011441:Propylthiouracil / Q000633:toxicity*
D011441:Propylthiouracil; D002994:Clofibrate